Biblio Discovery — Demo Discovery Service

38 results for "Eric A. Singer"

Showing 1–20 · 1.69 seconds · RSS

  1. Journal Article

    Unsupervised Domain Adaptation for Classification of Histopathology Whole-Slide Images

    Jian Ren; Ilker Hacihaliloglu; Eric A. Singer et al.

    Frontiers in Bioengineering and Biotechnology, Vol. 7 · 2019 · English · DOAJ Scopus

    Computational image analysis is one means for evaluating digitized histopathology specimens that can increase the reproducibility and reliability with which cancer diagnoses are rendered while simultaneously providing insight as to the underlying mechanisms of disease onset and progression. A major…

  2. Journal Article Full text

    Predictors of Recurrence for T3a RCC: A Recurring Conundrum

    Zev Leopold; Arnav Srivastava; Eric A. Singer

    Diagnostics, Vol. 10 No. 11 · 2020 · English · DOAJ Scopus

    Although the gold standard treatment for localized renal cell carcinoma (RCC) is radical nephrectomy (RN) or partial nephrectomy (PN), recurrence rates remain high at 7%, 26%, and 39% for T1, T2, and T3 staged disease, respectively [...]

  3. Journal Article

    Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy

    Jake Drobner; Daniella Portal; Karie Runcie et al.

    Journal of Kidney Cancer and VHL, Vol. 10 No. 3 · 2023 · English · DOAJ

    Non-clear cell renal cell carcinoma (nccRCC) is a heterogeneous group of malignancies that represents 25% of renal cell carcinoma (RCC) cases. Treatment for non-clear cell histologies is mostly based on evidence from small phase II clinical trials or extrapolated from successful therapies in clear…

  4. Journal Article

    Genomic and immunologic correlates of LAG-3 expression in cancer

    Anshuman Panda; Jeffrey A. Rosenfeld; Eric A. Singer et al.

    OncoImmunology, Vol. 9 No. 1 · 2020 · English · DOAJ Scopus

    Immune checkpoint blockade leads to unprecedented responses in many cancers. Although currently available agents mostly target the PD-1 and CTLA-4 pathways, agents targeting the immune checkpoint protein LAG-3 are under active clinical development, and early clinical data show that LAG-3 expression…

  5. Journal Article

    Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer

    Mark N Stein; Neal Patel; Alexander Bershadskiy et al.

    Asian Journal of Andrology, Vol. 16 No. 3 · 2014 · English · DOAJ Scopus

    Suppression of gonadal testosterone synthesis represents the standard first line therapy for treatment of metastatic prostate cancer. However, in the majority of patients who develop castration-resistant prostate cancer (CRPC), it is possible to detect persistent activation of the androgen receptor…

  6. Journal Article

    Statistical analysis of survival models using feature quantification on prostate cancer histopathological images

    Jian Ren; Eric A Singer; Evita Sadimin et al.

    Journal of Pathology Informatics, Vol. 10 No. 1 · 2019 · English · DOAJ Scopus

    Background: Grading of prostatic adenocarcinoma is based on the Gleason scoring system and the more recently established prognostic grade groups. Typically, prostate cancer grading is performed by pathologists based on the morphology of the tumor on hematoxylin and eosin (H and E) slides. In this…

  7. Journal Article

    Role of metastasectomy in the management of renal cell carcinoma

    Mark Mikhail; Kevin J. Chua; Labeeqa Khizir et al.

    Frontiers in Surgery, Vol. 9 · 2022 · English · DOAJ Scopus

    Treatment of metastatic renal cell carcinoma (mRCC) has evolved with the development of a variety of systemic agents; however, these therapies alone rarely lead to a complete response. Complete consolidative surgery with surgical metastasectomy has been associated with improved survival outcomes in…

  8. Journal Article Full text

    Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma

    Rohit K. Raj; Rituraj Upadhyay; Shang-Jui Wang et al.

    Current Oncology, Vol. 30 No. 12 · 2023 · English · DOAJ Scopus

    Stereotactic ablative radiotherapy (SABR) has challenged the conventional wisdom surrounding the radioresistance of renal cell carcinoma (RCC). In the past decade, there has been a significant accumulation of clinical data to support the safety and efficacy of SABR in RCC. Herein, we review the use…

  9. Journal Article

    Impact of inflammatory bowel disease on radical prostatectomy outcomes and costs of care

    Ilana P. Goldberg; Steven L. Chang; Shilajit D. Kundu et al.

    Prostate International, Vol. 9 No. 2 · 2021 · English · DOAJ Scopus

    Background: Recent studies suggest an association between prostate cancer and inflammatory bowel disease (IBD). Our objectives were to investigate clinical and financial impacts of IBD on radical prostatectomy (RP) and to determine the impact of surgical approach on our findings. Methods: The…

  10. Journal Article

    Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature

    Sho Yoshitake; Brian M. Shinder; Kevin Dazen et al.

    Journal of Kidney Cancer and VHL, Vol. 9 No. 2 · 2022 · English · DOAJ

    Renal cell carcinoma (RCC) metastases to the testicle are an extremely rare clinical entity. Here, we describe the case of a man with metastatic RCC who developed a new testicular mass. Pathologic analysis after surgical removal of this testicle confirmed the diagnosis of metastatic RCC. This…

    Also available at: DOAJ

  11. Journal Article

    Inflammatory Hibernoma of the Renal Hilum Mimicking a Renal Pelvis Tumor

    Kelsey Larkin; Kevin Chua; Sai Krishnaraya Doppalapudi et al.

    Journal of Kidney Cancer and VHL, Vol. 9 No. 1 · 2022 · English · DOAJ

    We report on an enhancing, heterogenous renal pelvis mass growing over 2 years which was found to be a benign hibernoma with inflammatory and lipomatous features originating from the renal hilum. To our knowledge, this is the first case reported on a hibernoma compressing on the renal pelvis and…

  12. Journal Article

    Active Surveillance in Metastatic Renal Cell Carcinoma

    Nicholas Beecroft; Timothy D. Gauntner; Rituraj Upadhyay et al.

    Journal of Kidney Cancer and VHL, Vol. 11 No. 2 · 2024 · English · DOAJ

    Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with a variable clinical course. While therapies for treatment of this condition have progressed, they are not without toxicity. In some patients, active surveillance (AS) of this disease is increasingly considered to delay its…

  13. Journal Article

    Modern Management of Localized Renal Cell Carcinoma— Is Ablation Part of the Equation?

    Zev Leopold; Rachel Passarelli; Mark Mikhail et al.

    Journal of Kidney Cancer and VHL, Vol. 9 No. 3 · 2022 · English · DOAJ

    While the gold-standard for management of localized renal cell carcinoma (RCC) is partial nephrectomy, recent ablative strategies are emerging as alternatives with comparable rates of complications and oncologic outcomes. Thermal ablation, in the form of radiofrequency ablation and cryoablation, is…

  14. Journal Article

    Surgical Management of Advanced and Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach

    Brian M. Shinder; Kevin Rhee; Douglas Farrell et al.

    Frontiers in Oncology, Vol. 7 · 2017 · English · DOAJ Scopus

    The past decade has seen a rapid proliferation in the number and types of systemic therapies available for renal cell carcinoma. However, surgery remains an integral component of the therapeutic armamentarium for advanced and metastatic kidney cancer. Cytoreductive surgery followed by adjuvant…

  15. Journal Article

    Examining the Role of Microbiota-Centered Interventions in Cancer Therapeutics: Applications for Urothelial Carcinoma

    Jake C. Drobner BA; Benjamin J. Lichtbroun MD; Eric A. Singer MD, MA, MS, FACS, FASCO et al.

    Technology in Cancer Research & Treatment, Vol. 22 · 2023 · English · DOAJ Scopus

    Modern advances in genomic and molecular technologies have sparked substantial research on the human intestinal microbiome over the past decade. A deeper understanding of the microbiome has illuminated that dysbiosis, or a disruption in the microbiome, is associated with inflammatory disease states…

  16. Journal Article

    Changes in prostate cancer survival among insured patients in relation to USPSTF screening recommendations

    Isaac E. Kim; Daniel D. Kim; Sinae Kim et al.

    BMC Urology, Vol. 22 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background To investigate the effects of the U.S. Preventive Services Task Force’s (USPSTF) 2012 recommendation against prostate-specific antigen (PSA)-based screening for prostate cancer on survival disparities based on insurance status. Prior to the USPSTF’s 2012 screening…